CN Patent

CN109415329B — 合成方法

Assigned to GlaxoSmithKline Intellectual Property No 2 Ltd · Expires 2023-05-12 · 3y expired

What this patent protects

公开了用于制备以下化合物的方法。所述化合物可以被掺入药物制剂中，包括片剂，并且这样的片剂可以用于治疗胆汁郁积性肝病。

USPTO Abstract

公开了用于制备以下化合物的方法。所述化合物可以被掺入药物制剂中，包括片剂，并且这样的片剂可以用于治疗胆汁郁积性肝病。

Drugs covered by this patent

Patent Metadata

Patent number
CN109415329B
Jurisdiction
CN
Classification
—
Expires
2023-05-12
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline Intellectual Property No 2 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.